|
Human Nutrition Research Information Management (HNRIM) System
|
Resource Development
|
CDC, FDA, HRSA
|
NIDDK
|
The Human Nutrition Research Information Management (HNRIM) System is a searchable database of nutrition research and research training activities supported by the Federal government and maintained by the NIH Division of Nutrition Research Coordination (DNRC).
|
|
IAA with CDC for HPTN 052: A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples
|
Research Initiative
|
CDC
|
NIAID
|
These clinical studies are based on data collected in Africa and Thailand. There is a correlation between HIV viral load (blood levels) and HIV transmission. Specifically, the higher the viral load in the blood, the more likely the chance for transmission. Antiretroviral therapy (ART) reduces the viral load in the blood, as well as in genital secretions (for both men and women), and the drugs can be detected in semen and vaginal and cervical secretions. This information strongly suggests that ART may reduce the risk that HIV-infected people will transmit HIV. HPTN 052 compares the HIV-infection rates of two groups of HIV-serodiscordant couples.
|
|
ICARE: Interagency Collaborative to Advance Research in Epilepsy
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NINDS, FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH
|
The Interagency Collaborative to Advance Research in Epilepsy (ICARE) is an interagency epilepsy working group that includes broad representation across the NIH ICs involved in epilepsy-related research, as well as across HHS and other Federal agencies and multiple epilepsy research and patient advocacy groups with a primary focus on biomedical research. The purpose of this group, which is led by the National Institute of Neurological Disorders and Stroke, is to increase communication among institutes and agencies sponsoring epilepsy-related research and explore opportunities for increased coordination. The group’s annual meetings provide a forum for sharing information about ongoing and planned epilepsy research activities, highlighting advances, discussing needs and opportunities, and promoting increased collaboration toward common research goals.
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
This collaboration will lead to safer and more effective treatment planning and performance of image-guided interventions and therapeutic drug delivery. The results of all of these studies of image guided interventions and related technologies and the models used to study them will have a direct impact on the effectiveness and consistency of the FDA Center for Devices and Radiological Health''s preclinical review of device applications while meeting the primary research goal of optimizing image guided interventions and pre-clinical modeling of those interventions. Regulatory science and translational therapeutics have overlapping goals when it comes to drugs and devices combination therapies.
|
|
Immune Responses after Papillomavirus Vaccination
|
Other
|
CDC
|
NIAID
|
In this collaboration, the Human Papillomavirus (HPV) Laboratory of the Centers for Disease Control and Prevention (CDC) analyzes the antibody response to HPV vaccination in samples collected during an National Institute of Allergy and Infectious Diseases (NIAID) study examining the varying immune responses of adolescents receiving the HPV vaccine on schedule and with altered immunization intervals.
|
|
Improving Technical Standards and Molecular Tools for Probiotics Research and Development
|
Research Initiative
|
FDA
|
NCCAM
|
In 2008, the USDA Agricultural Service initiated a Memorandum of Understanding (MOU) with NCCAM to exchange expertise in technology development and partner research initiatives to advance the field of probiotic biology and role in human health. The MOU consists of a five year plan defining common mission goals; expected benefits from the exchange of research expertise and resources; and demonstration projects based on NIH/NCCAM funded U01 cooperative agreements. The long-term goal of the MOU is to develop trans-agency networked initiatives. In 2012, the unique resources of the USDA Agricultural Research Service and the Human Microbiome Project investigators were successfully implemented as a parallel comparative biotechnologies validation and standardization prototype with targeted molecular approaches.
|
|
Industry Wide Exposure Assessment Study of Workers to Carbon Nanotubes and Nanonfibers
|
Research Initiative
|
CDC
|
NIEHS
|
This study will measure workplace exposures to carbon nanotubes and carbon nanofibers among a representative sample of US manufacturers and downstream users.
|
|
Influenza Risk Management Meeting
|
Other
|
CDC, FDA, OS
|
NIAID
|
The Influenza Risk Management Meeting meetings provide members with a venue to discuss issues relating to the U.S. Department of Health and Human Services (HHS) response to pandemic influenza. Subjects for discussion include but are not limited to considerations of vaccine and antiviral stockpiles and clinical trial response to influenza outbreaks such as H7N9 and H3N2v.
|
|
Influenza Vaccine Manufacturing Improvement Group
|
Other
|
CDC, FDA, OS
|
NIAID
|
The Influenza Vaccine Manufacturing Improvement Group aims to optimize donor strains, improve sterility assays, and develop alternative potency assays.
|
|
Inter-Agency Committee on Drug Control (ICDC)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS, SAMHSA
|
NIDA
|
The Inter-Agency Committee on Drug Control (ICDC) serves to facilitate communication between government agencies, including NIDA, FDA, DEA, and SAMHSA regarding drug control policies and initiatives.
|